2 Citations (Scopus)

Abstract

Background: Postresection intestinal adaptation is an augmented self-renewal process that might increase the risk of malignant transformation in the intestine. Furthermore, patients with short bowel syndrome (SBS) have other characteristics that might increase this risk. Our aim was to determine the incidence of new intestinal malignancy in SBS patients. Methods: We reviewed the records of 500 adult SBS patients identified from 1982-2013. There were 199 men and 301 women ranging in age from 19-91 years. Follow-up from the time of diagnosis of SBS ranged from 12-484 months. A total of 186 (37%) patients were followed >5 years. Results: The cause of SBS was postoperative in 35% of patients, malignancy/radiation in 19%, mesenteric vascular disease in 17%, Crohn's disease in 16%, and other in 13%. Twenty-eight (6%) patients received growth stimulatory medications. Fifteen percent of patients had a prior total colectomy. Twenty-eight (6%) patients underwent intestinal transplantation, and 115 (23%) patients had a previous abdominal malignancy, including colorectal cancer in 43 patients. Thirty-six (7%) received radiation therapy. Recurrent colon cancer was found in 2 patients, one at a stoma and the other with lung metastases. New colon cancer was found in 1 patient (0.2%), a 62-year-old woman with long-standing Crohn's disease. Conclusion: The incidence of colon cancer in this heterogenous group of patients with SBS was similar to that of the normal population. This suggests that the risk of developing a new colon cancer in patients with SBS is not increased.

Original languageEnglish (US)
Pages (from-to)562-565
Number of pages4
JournalJournal of Parenteral and Enteral Nutrition
Volume41
Issue number4
DOIs
StatePublished - May 1 2017

Fingerprint

Short Bowel Syndrome
Neoplasms
Colonic Neoplasms
Crohn Disease
Colectomy
Incidence
Vascular Diseases

Keywords

  • colon cancer
  • intestinal adaptation
  • short bowel syndrome

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Risk of Intestinal Malignancy in Patients with Short Bowel Syndrome. / Thompson, Jon S; Weseman, Rebecca A.; Mercer, David F; Rochling, Fedja A; Vargas, Luciano M; Grant, Wendy J.; Langnas, Alan Norman.

In: Journal of Parenteral and Enteral Nutrition, Vol. 41, No. 4, 01.05.2017, p. 562-565.

Research output: Contribution to journalArticle

@article{063f4caa17a24181b36a4b6c324117e1,
title = "Risk of Intestinal Malignancy in Patients with Short Bowel Syndrome",
abstract = "Background: Postresection intestinal adaptation is an augmented self-renewal process that might increase the risk of malignant transformation in the intestine. Furthermore, patients with short bowel syndrome (SBS) have other characteristics that might increase this risk. Our aim was to determine the incidence of new intestinal malignancy in SBS patients. Methods: We reviewed the records of 500 adult SBS patients identified from 1982-2013. There were 199 men and 301 women ranging in age from 19-91 years. Follow-up from the time of diagnosis of SBS ranged from 12-484 months. A total of 186 (37{\%}) patients were followed >5 years. Results: The cause of SBS was postoperative in 35{\%} of patients, malignancy/radiation in 19{\%}, mesenteric vascular disease in 17{\%}, Crohn's disease in 16{\%}, and other in 13{\%}. Twenty-eight (6{\%}) patients received growth stimulatory medications. Fifteen percent of patients had a prior total colectomy. Twenty-eight (6{\%}) patients underwent intestinal transplantation, and 115 (23{\%}) patients had a previous abdominal malignancy, including colorectal cancer in 43 patients. Thirty-six (7{\%}) received radiation therapy. Recurrent colon cancer was found in 2 patients, one at a stoma and the other with lung metastases. New colon cancer was found in 1 patient (0.2{\%}), a 62-year-old woman with long-standing Crohn's disease. Conclusion: The incidence of colon cancer in this heterogenous group of patients with SBS was similar to that of the normal population. This suggests that the risk of developing a new colon cancer in patients with SBS is not increased.",
keywords = "colon cancer, intestinal adaptation, short bowel syndrome",
author = "Thompson, {Jon S} and Weseman, {Rebecca A.} and Mercer, {David F} and Rochling, {Fedja A} and Vargas, {Luciano M} and Grant, {Wendy J.} and Langnas, {Alan Norman}",
year = "2017",
month = "5",
day = "1",
doi = "10.1177/0148607115609587",
language = "English (US)",
volume = "41",
pages = "562--565",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Risk of Intestinal Malignancy in Patients with Short Bowel Syndrome

AU - Thompson, Jon S

AU - Weseman, Rebecca A.

AU - Mercer, David F

AU - Rochling, Fedja A

AU - Vargas, Luciano M

AU - Grant, Wendy J.

AU - Langnas, Alan Norman

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background: Postresection intestinal adaptation is an augmented self-renewal process that might increase the risk of malignant transformation in the intestine. Furthermore, patients with short bowel syndrome (SBS) have other characteristics that might increase this risk. Our aim was to determine the incidence of new intestinal malignancy in SBS patients. Methods: We reviewed the records of 500 adult SBS patients identified from 1982-2013. There were 199 men and 301 women ranging in age from 19-91 years. Follow-up from the time of diagnosis of SBS ranged from 12-484 months. A total of 186 (37%) patients were followed >5 years. Results: The cause of SBS was postoperative in 35% of patients, malignancy/radiation in 19%, mesenteric vascular disease in 17%, Crohn's disease in 16%, and other in 13%. Twenty-eight (6%) patients received growth stimulatory medications. Fifteen percent of patients had a prior total colectomy. Twenty-eight (6%) patients underwent intestinal transplantation, and 115 (23%) patients had a previous abdominal malignancy, including colorectal cancer in 43 patients. Thirty-six (7%) received radiation therapy. Recurrent colon cancer was found in 2 patients, one at a stoma and the other with lung metastases. New colon cancer was found in 1 patient (0.2%), a 62-year-old woman with long-standing Crohn's disease. Conclusion: The incidence of colon cancer in this heterogenous group of patients with SBS was similar to that of the normal population. This suggests that the risk of developing a new colon cancer in patients with SBS is not increased.

AB - Background: Postresection intestinal adaptation is an augmented self-renewal process that might increase the risk of malignant transformation in the intestine. Furthermore, patients with short bowel syndrome (SBS) have other characteristics that might increase this risk. Our aim was to determine the incidence of new intestinal malignancy in SBS patients. Methods: We reviewed the records of 500 adult SBS patients identified from 1982-2013. There were 199 men and 301 women ranging in age from 19-91 years. Follow-up from the time of diagnosis of SBS ranged from 12-484 months. A total of 186 (37%) patients were followed >5 years. Results: The cause of SBS was postoperative in 35% of patients, malignancy/radiation in 19%, mesenteric vascular disease in 17%, Crohn's disease in 16%, and other in 13%. Twenty-eight (6%) patients received growth stimulatory medications. Fifteen percent of patients had a prior total colectomy. Twenty-eight (6%) patients underwent intestinal transplantation, and 115 (23%) patients had a previous abdominal malignancy, including colorectal cancer in 43 patients. Thirty-six (7%) received radiation therapy. Recurrent colon cancer was found in 2 patients, one at a stoma and the other with lung metastases. New colon cancer was found in 1 patient (0.2%), a 62-year-old woman with long-standing Crohn's disease. Conclusion: The incidence of colon cancer in this heterogenous group of patients with SBS was similar to that of the normal population. This suggests that the risk of developing a new colon cancer in patients with SBS is not increased.

KW - colon cancer

KW - intestinal adaptation

KW - short bowel syndrome

UR - http://www.scopus.com/inward/record.url?scp=85018774624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018774624&partnerID=8YFLogxK

U2 - 10.1177/0148607115609587

DO - 10.1177/0148607115609587

M3 - Article

C2 - 26419925

AN - SCOPUS:85018774624

VL - 41

SP - 562

EP - 565

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 4

ER -